Implantable Left Atrial Hemodynamic Monitor — CPB 0832 | AETNA Coverage Update

TL;DR: Aetna modified CPB 0832 for implantable left atrial hemodynamic monitors, effective December 10, 2025. CPT codes 0933T and 0934T are not covered under this policy. Here's what billing teams need to know.

Aetna, a CVS Health company, updated its implantable left atrial hemodynamic monitor coverage policy under CPB 0832 in December 2025. The policy covers devices like the HeartPOD System, Promote LAP System, and V-LAP System — all of which Aetna classifies as experimental, investigational, or unproven. The two primary codes affected are CPT 0933T (transcatheter implantation of a wireless left atrial pressure sensor) and CPT 0934T (remote monitoring of that sensor for up to 30 days). If your practice manages heart failure patients and has been billing — or considering billing — for left atrial pressure monitoring, this policy change shuts that door at Aetna.

Quick-Reference Table

Aetna Implantable Left Atrial Hemodynamic Monitor Coverage Criteria and Medical Necessity Requirements 2025

The Aetna implantable left atrial hemodynamic monitor coverage policy under CPB 0832 is unambiguous: there is no covered indication. Aetna does not recognize medical necessity for these devices under any heart failure diagnosis in the I50 category.

The Aetna left atrial hemodynamic monitor billing guidelines do not include a pathway to medical necessity approval. There are no criteria you can meet, no clinical documentation thresholds to clear, and no patient profiles that qualify. This is a blanket exclusion based on Aetna's assessment that peer-reviewed evidence is insufficient to support the technology.

Whether your patient carries any heart failure diagnosis across the I50.1–I50.9 range — including I50.2, I50.3, or I50.4 — the answer from Aetna is the same. Prior authorization won't help here — there's no path to approval to request.

That said, if you're a larger practice with a payer contract or a complex population that might justify a reconsideration request, talk to your billing consultant or medical director before writing this off entirely. Payer exceptions exist. They're rare, and they require a strong clinical and administrative case, but they're not impossible.

Aetna Implantable Left Atrial Hemodynamic Monitor Exclusions and Non-Covered Indications

Aetna explicitly classifies implantable left atrial hemodynamic monitors as experimental, investigational, or unproven. That language matters for your denial management workflow — it tells you exactly how Aetna will code a denial and what your appeal trajectory looks like (spoiler: it's steep).

The three named device systems in the policy are the HeartPOD System, the Promote LAP System, and the V-LAP System. If a manufacturer's representative is presenting a different branded system to your cardiac program, check whether it falls under this same policy framework before any implantation discussion begins.

The experimental designation is grounded in Aetna's review of peer-reviewed literature. Aetna determined the clinical evidence does not meet its threshold for coverage. Until that evidence base changes — and until Aetna updates CPB 0832 to reflect it — reimbursement for these devices is off the table.

This is distinct from a "not medically necessary" denial on an individual claim basis. An experimental designation applies categorically. That distinction matters if you're considering an appeal: you're not arguing this patient's specific clinical picture, you're arguing against the policy classification itself. Those appeals require clinical literature, not just a physician letter of medical necessity.

Coverage Indications at a Glance

Aetna Left Atrial Hemodynamic Monitor Billing Guidelines and Action Items 2025

This policy took effect December 10, 2025. If your team hasn't acted yet, act now. Here's what to do.

CPT, HCPCS, and ICD-10 Codes for Implantable Left Atrial Hemodynamic Monitor Under CPB 0832

Not Covered / Experimental CPT Codes

These are the two codes at the center of this policy. Neither has a covered indication under Aetna CPB 0832. Do not submit these codes for Aetna-insured patients expecting reimbursement.

Both 0933T and 0934T carry no covered indication under this policy. Based on general CPT coding knowledge — not derived from CPB 0832 itself — these are Category III codes, which are temporary codes for emerging technologies. Aetna's experimental designation aligns with that broader positioning, but confirm code category details with your CPT codebook rather than relying on the policy text.

Key ICD-10-CM Diagnosis Codes Referenced in CPB 0832

These heart failure diagnosis codes appear in the policy. Their presence confirms Aetna's awareness of the clinical context — and its decision to exclude coverage regardless of which heart failure subtype is documented.

Note: The source policy lists the description for all I50.x subcategories as "Heart failure." More granular descriptions are not provided in CPB 0832.

The full I50 subcategory range is covered — or more precisely, excluded. There is no heart failure diagnosis that creates a covered pathway for 0933T or 0934T under this Aetna coverage policy.